July 30, 2025

Mortality Among Surgeons in the United States 

National mortality data reveal that surgeons face higher death rates than non-surgeon physicians, with cancer and external causes contributing prominently.

Conexiant

July 31, 2025

‘Victim-Blaming’ in Public Health?

As Trump’s health officials push personal responsibility, critics warn their rhetoric blames patients, shapes policy, and risks deepening health inequalities.

KFF Health News

July 25, 2025

Spontaneous Urticaria Carries Greater Burden, Costs

Researchers assess how disease type, comorbidities, and treatment knowledge shape clinical outcomes and healthcare use in patients with chronic urticaria.

Conexiant

July 21, 2025

Remdesivir Not Tied to Cardiac Risk

In a meta-analysis of 4566 patients with COVID-19, researchers found no statistically significant increase in cardiac adverse events associated with remdesivir treatment and concluded that the drug does not raise heart-related safety concerns.

Conexiant

July 21, 2025

Stanford Physician-Scientist Takes CDER Helm

Stanford's George Tidmarsh appointed FDA's new CDER director, bringing 30+ years biotechnology experience and seven approved drugs.

Conexiant

July 17, 2025

Metformin Ineffective for COVID Recovery, Trial Finds

Researchers found metformin did not significantly shorten COVID-19 symptom duration in low-risk outpatients, though it was safe and well tolerated.

Conexiant

July 17, 2025

Cancer History Linked to Severe COVID-19, Study 

Adult childhood cancer survivors had a higher risk of severe COVID-19 despite lower infection rates and higher vaccination coverage.

Conexiant

July 16, 2025

New Guidelines Target Preventive Gaps in Inflammatory Bowel Disease

New clinical recommendations detail updated vaccination and screening protocols to reduce infection and cancer risks in adults with inflammatory bowel disease, particularly those on immune-modifying therapies.

Conexiant

July 14, 2025

Potential Links Between Infection and Alzheimer’s Disease

Researchers examine the potential contribution of Chlamydia pneumoniae and SARS-CoV-2 infections to Alzheimer’s disease pathogenesis, focusing on neuroinflammatory mechanisms and genetic factors such as APOEε4.

Conexiant